Nuclear Medicine/Radiopharmaceuticals Market : The Development Strategies Adopted By Major Key Players And To Understand The Competitive Scenario

Market Values:

The Nuclear Medicine/Radiopharmaceuticals Market was worth US $5.55 billion in 2022, with a CAGR of 9%.
By 2029, the market is expected to reach US $10.14 billion.

To Know More About The Report :https://www.maximizemarketresearch.com/market-report/global-nuclear-medicine-radiopharmaceuticals-market/7741/

Report Scope: The report offers a detailed analysis of the Global Nuclear Medicine/Radiopharmaceuticals Market, including market drivers, restraints, opportunities, and challenges. It encompasses market segmentation by type, procedural volume, application, and geography. Key highlights include assessment of market dynamics, competitive outlook, and strategic business planning insights.

Research Methodology: The research methodology involves triangulation of data points from various sources and feeding them into a simulation model. Data points are obtained from paid and unpaid sources, along with paid primary interviews with key opinion leaders (KOLs). The report includes comprehensive analysis and forecast for five major geographies: North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

To know about the Research Methodology :https://www.maximizemarketresearch.com/request-sample/7741

Drivers:

Increasing incidence and prevalence of cancer and cardiac ailments.
Growing adoption of modern treatments and diagnostic procedures.
Raising awareness regarding the advantages of radiopharmaceuticals.

Restraints:

High cost of nuclear medicine equipment.

Regional Insights:

North America expected to dominate the market, followed by Europe and APAC.
Well-established healthcare industry and rising awareness contribute to market growth in North America.
Presence of extensive usage of SPECT radioisotopes for diagnosis drives market growth in APAC.

Key Highlights:

Assessment of market definition, key players, and competitive outlook.
Comprehensive quantitative analysis from 2017 to 2024.
In-depth analysis of market segments, dynamics, and competition.
Detailed segmentation by type, procedural volume, application, and geography.
Forecast for five major geographies and their key regions.

To access more comprehensive information, click here:https://www.maximizemarketresearch.com/request-sample/7741

Segmentation:

by Procedures

Cardiovascular
Oncology
Central Nervous System
Skeletal
Endocrine
Gastrointestinal
Pulmonary

by Type

Therapeutic
Alpha Emitters
Beta Emitters
Brachytherapy Isotopes
Diagnostic
PET Radiopharmaceuticals
SPECT Radiopharmaceuticals

by Application

Cardiology
Oncology
Thyroid
Neurology
Others

by End-User

Research Institutes
Hospitals
Diagnostic Centers
Others

Key Players

1. Advanced Accelerator Applications S.A.
2. Iba Molecular
3. Nordion, Inc. (A Subsidiary of Sterigenics International LLC.)
4. Eczacibasi-Monrol Nuclear Products
5. Siemens Healthcare
6. Sigma Aldrich Corporation
7. Bracco Imaging S.P.A
8. Bayer AG
9. Jubilant Pharma
10.Nordien, Inc.
11.Lantheus Medical Imaging, Inc.
12.GE Healthcare (A Fully-Owned Subsidiary of General Electric Company)
13.Mallinckrodt PLC
14.Cardinal Health, Inc.
15.Medtronic Plc.
16.Norgine B. V.
17.Curium
18.Eckert & Ziegler
19.NTP Radioisotopes

To access more comprehensive information, click here:https://www.maximizemarketresearch.com/request-sample/7741

Key Target Audience:

Research and Consulting Firms, Venture capitalists, private equity firms, and startup companies.
Radiopharmaceutical/Radioisotope Manufacturers and Distributors.
Healthcare Institutions, Contract Manufacturing Organizations (CMOs), Contract research organizations (CROs), and Government Bodies.
Market Scope: The report covers market segmentation by procedures, type, application, end-user, and geography. Key players include Advanced Accelerator Applications S.A., Iba Molecular, Nordion, Inc., Siemens Healthcare, Sigma Aldrich Corporation, and others.

Frequently Asked Questions:

Growth rate of Global Nuclear Medicine/Radiopharmaceuticals Market: CAGR of 9% during the forecast period 2023-2029.
Segments covered: Type, process, application, end-user, and region.
Key players: Advanced Accelerator Applications S.A., Iba Molecular, Nordion, Inc., Siemens Healthcare, Sigma Aldrich Corporation, and others.
Study period: 2022 to 2029.

Our Top Trending Reports

India Steam Boiler Systems Market https://www.maximizemarketresearch.com/market-report/india-steam-boiler-systems-market/46997/

Global Alzheimer's Therapeutics Market https://www.maximizemarketresearch.com/market-report/alzheimers-therapeutics-market/164747/

Aesthetic Medical Devices Market https://www.maximizemarketresearch.com/market-report/aesthetic-medical-devices-market/169746/

Hybrid Heat Pump Market https://www.maximizemarketresearch.com/market-report/hybrid-heat-pump-market/147438/

North America Battery Energy Storage System Market https://www.maximizemarketresearch.com/market-report/north-america-battery-energy-storage-system-market/6744/

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Banglore Highway, Narhe,

Pune, Maharashtra 411041, India

sales@maximizemarketresearch.com

+91 96071 95908, +91 9607365656

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.